Home » Topics » Regulatory » Patents

Patents
RSS

Another series of substance P antagonists discovered at Pfizer

April 30, 1998

Roche describes new agents for neurodegenerative disorders

April 30, 1998

New polythiophene antitumor agents for treating slow-growing tumors

April 29, 1998

Takeda presents agents inhibiting PDGF activity for renal, cardiovascular disorders

April 29, 1998

Cephalosporin antibiotics developed at Roche

April 29, 1998

Pfizer claims agents for myelosuppression and for activating the immune system

April 29, 1998

Antibacterial amide derivatives of amythiamicin claimed by Japanese institute

April 29, 1998

Ionotropic glutamate receptor ligands for neurological and CNS disorders

April 28, 1998

Takeda reveals novel inhibitors of Na+/H+ exchange

April 28, 1998

Substance P antagonists from Pfizer especially useful for pain, inflammation

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...